IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.
about
Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity ReactionsAllergen Immunotherapy: Past, Present, and FutureB cells with regulatory properties in transplantation toleranceImmunoregulatory T cell epitope peptides: the new frontier in allergy therapyRegulatory B cells: an exciting target for future therapeutics in transplantationNew treatments for allergen immunotherapyTolerance in Kidney Transplantation: What Is on the B Side?Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirsInsulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.CX3CR1(+) B cells show immune suppressor properties.Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis.Molecular biomarkers for grass pollen immunotherapy.Immunology of IgG4-related disease.Immunology of human schistosomiasis.Mechanisms of immune tolerance to allergens: role of IL-10 and TregsHuman CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytesGlioma-derived ADAM10 induces regulatory B cells to suppress CD8+ T cells.Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease.Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy.Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.Molecular and cellular mechanisms of food allergy and food tolerance.Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinEffects of allergic diseases and age on the composition of serum IgG glycome in children.Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A HypothesisLong-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.Food allergy: immune mechanisms, diagnosis and immunotherapyMechanisms of immune tolerance to allergens in childrenIgE immunotherapy: a novel concept with promise for the treatment of cancer.Role of Regulatory Cells in Oral Tolerance.Characterization of the Highly Prevalent Regulatory CD24hiCD38hi B-Cell Population in Human Cord Blood.Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy.Food allergy: management, diagnosis and treatment strategies.The role of B regulatory cells and Semaphorin3A in atopic diseases.Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.Regulatory functions of B cells in allergic diseases.
P2860
Q26764848-3696045C-54EF-498E-B0A0-B1E405B88BFAQ26765974-F8DA6BF8-0058-4357-B925-3D55BECE9DE1Q26771404-F7FB2AEA-EE29-49CD-A8FD-DF78CAC6929BQ26822702-8DC56F72-8E75-4438-8C89-3B67C0224012Q27015093-9A19458F-BE9F-415F-B823-AD9034B2BCA6Q27016089-66F308F7-9B82-4EAF-9053-4474E099752BQ28073964-ED2575B6-9940-4B9F-8B68-DEAF213EB641Q30251797-A61FF71D-D5B8-4700-BCCA-490B234F3075Q30276174-BF6994B4-7036-4AE4-AC06-8CE6F0AC63EBQ30402227-2F8B4114-DCD7-4A2F-9E5B-248FA7C61E1DQ31158755-15E3FB82-0337-47FB-91AC-883F0238097EQ33793070-F3B1CDC6-201C-4CE1-8C0A-5A4FE009B438Q34044562-EB825762-8A41-47E6-B997-BF1A6FF33862Q34056484-8588869B-B1B6-4741-A56A-1271D3F69F51Q34093047-65A7B53F-B174-445C-A4F4-6C13C6FBFB93Q34471314-3C906AD6-CF5B-4DBF-8DAE-D3710367F729Q34782228-B4F50036-0E53-4358-8A78-DBF29D8CD961Q35140130-BC0D300E-C57C-4176-A568-977D857A586AQ35156154-A706ACDC-90DC-49C6-92E8-16743F21A476Q35225653-D88D4315-CF02-45B5-A11E-5B3E84D37C2AQ35351104-0F673E63-7768-4D8D-9FE0-BA10487869F9Q35577604-FEB78842-D23E-4E9A-AAF0-B39B6044148AQ35625089-6D29F5C3-1401-407C-BAA6-DFF8EBD97F1CQ35828399-656D6E1B-2B1F-4AA8-8C8C-B510891001A7Q35984123-2596AA8D-25D1-46E0-A61A-74BC2212AE40Q36484465-86DF8C4A-8107-40C7-B074-FC05F2225BA8Q37093267-FFF124B0-DD73-488F-90C0-B247370F453EQ37248132-FE59E9CD-6462-40BE-85F6-57844670F1E0Q37293213-0C483802-9994-4E3E-AEAD-121AF49947D2Q37394520-6F2870D9-0988-4C62-831F-2B65FC60916DQ37442005-CB6F9919-C4F8-47FE-8A8C-33061DB4A04AQ37453510-15D657B0-6FA4-431E-9823-286B4485B9CAQ37593712-9F2162DC-0AD6-43AA-BAEA-31BC7DE73A8DQ37606265-2F49FB6F-3DF0-4DB1-8D03-68B612C432F4Q37683167-900EFF5F-83B0-4DD7-9EC7-C92AC0F759AEQ37732900-D0E75E97-7AA2-4F94-8F4E-ED43D4A2299BQ38119552-57124DE5-35F2-4535-AB69-6045B3DC6828Q38203097-903A812F-5B50-457C-A2C1-481BDC37D7AFQ38233294-326C914F-1C43-44F5-A41D-39CB21D49B2EQ38233691-13B7A8B5-80B7-4739-99C8-76289EA596A7
P2860
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
IgG4 production is confined to ...... gen-specific immune responses.
@ast
IgG4 production is confined to ...... gen-specific immune responses.
@en
IgG4 production is confined to ...... gen-specific immune responses.
@nl
type
label
IgG4 production is confined to ...... gen-specific immune responses.
@ast
IgG4 production is confined to ...... gen-specific immune responses.
@en
IgG4 production is confined to ...... gen-specific immune responses.
@nl
prefLabel
IgG4 production is confined to ...... gen-specific immune responses.
@ast
IgG4 production is confined to ...... gen-specific immune responses.
@en
IgG4 production is confined to ...... gen-specific immune responses.
@nl
P2093
P1476
IgG4 production is confined to ...... gen-specific immune responses.
@en
P2093
Barbara Stanic
Beate Rückert
Deniz G Akdis
Görkem Yaman
Marcin Wawrzyniak
Mübeccel Akdis
Stefan Söllner
Willem van de Veen
P304
P356
10.1016/J.JACI.2013.01.014
P407
P577
2013-02-26T00:00:00Z